2007
Genetic testing in young women with breast cancer: Results from a web-based survey
Shin J, Gelber S, Garber J, Rosenberg R, Przypyszny M, Winer E, Partridge A. Genetic testing in young women with breast cancer: Results from a web-based survey. Journal Of Clinical Oncology 2007, 25: 21093-21093. DOI: 10.1200/jco.2007.25.18_suppl.21093.Peer-Reviewed Original ResearchBreast cancerOvarian cancerFamily historyGenetic testingYoung womenWeb-based surveyYoung breast cancer survivorsTime of diagnosisBreast cancer survivorsHigh-risk populationMajority of womenFear of recurrenceQuality of lifeCross-sectional surveyLarge web-based surveyBreast cancer diagnosisCancer survivorsBRCA1/2 mutationsAge 40Baseline anxietyNumber of childrenFertility issuesCancerMultivariate modelSignificant financial relationshipHow well do standard prognostic criteria predict oncotype DX (ODX) scores?
Kamal A, Loprinzi C, Reynolds C, Dueck A, Geiger X, Ingle J, Carlson R, Hobday T, Winer E, Perez E, Goetz M. How well do standard prognostic criteria predict oncotype DX (ODX) scores? Journal Of Clinical Oncology 2007, 25: 576-576. DOI: 10.1200/jco.2007.25.18_suppl.576.Peer-Reviewed Original ResearchODX scoresPrognostic criteriaBreast cancerExpert breast pathologistsMayo Clinic patientsOncotype DX scoreAssessment of ERAdjuvant chemotherapyIntermediate riskBreast pathologistsClinic patientsTumor sizeAcademic oncologistsTumor gradeHigh riskTumor slidesStandardized criteriaClinical casesPatientsOncologistsGene expression profilingSignificant financial relationshipChemotherapyODXScoresDose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study
Burstein H, Mayer E, Peppercorn J, Parker L, Hannagan K, Moy B, Younger J, Schapira L, Wulf G, Gelman R, Winer E. Dose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study. Journal Of Clinical Oncology 2007, 25: 594-594. DOI: 10.1200/jco.2007.25.18_suppl.594.Peer-Reviewed Original ResearchG-CSF supportNab-paclitaxelFebrile neutropeniaTreatment delayBreast cancerDoxorubicin/cyclophosphamideNab-paclitaxel therapyQuality of lifeDose-denseAdjuvant chemotherapyEligible patientsNeoadjuvant chemotherapyTaxane chemotherapyDose reductionFull cohortStage IPatientsNeutropeniaChemotherapyInstitutional studyPaclitaxelSignificant financial relationshipCycle 6CancerPrior studies
2006
Use of experimental therapy outside of clinical trials among U.S. oncologists
Peppercorn J, Joffe S, Burstein H, Winer E. Use of experimental therapy outside of clinical trials among U.S. oncologists. Journal Of Clinical Oncology 2006, 24: 6047-6047. DOI: 10.1200/jco.2006.24.18_suppl.6047.Peer-Reviewed Original ResearchClinical trialsPractice settingsInvestigational cancer therapiesAttitudes of physiciansDemographic factorsU.S. oncologistsCommunity oncologistsMedical oncologistsTrial enrollmentAcademic oncologistsRecent trialsExperimental therapiesPatient's requestAmerican oncologistsOncology communityGuideline developmentOncologistsPatientsSignificant financial relationshipTrialsMonthsCancer therapyTherapyRandom sampleCare